Disclaimer

The trademark information displayed on this page is public information and is provided for informational purposes only. This information may be incomplete, inaccurate, or outdated, and IndiaFilings does not guarantee its accuracy. IndiaFilings is an independent platform and is not associated, affiliated, or connected with any trademark listed in this database. We do not represent or speak on behalf of any such trademark. If you are trying to contact a specific trademark, please use their official channels. IndiaFilings cannot assist with queries directed at other companies.

MBRACE THERAPEUTICS & Design

Class 99Status: Accepted & Advertised
Trademark Logo
Application Number6352148
Trademark Status
Accepted & Advertised
Trademark Class99
Application Date2024-03-18
Proprietor NameMBrace Therapeutics, Inc.
Appropriate OfficeDELHI
StateHARYANA
Trademark TypeDEVICE
User DetailsProposed to be used
Agent NameMETTLE LEGAL[30237]
Agent AddressH-124, Second Floor, Residency Greens, Greenwood City, Sector-46, Gurgaon, Haryana-122001
Goods And Services Details[CLASS : 5] Antibody drug conjugate being medicines which deliver chemotherapy agents to kill cancer cells and/or abort cell multiplication; Tumor suppressing agents; Pharmaceutical preparations for suppressing tumors.[CLASS : 44] Antibody testing for medical diagnostic or treatment purposes.

Trademark Protection

Automate the monitoring of your trademark application and filing of response to Government Objection or Hearing.

₹9,899+ GST

What's included:

✓
Brand Guard ( 1 application 1 class)
✓
Appointment of Lawyer
✓
Objection
✓
Hearing
✓
Infringement support (1)
✓
Power of Attorney (POA)

Frequently asked questions

Common questions about MBRACE THERAPEUTICS & Design.

The current status of trademark application 6352148 for MBRACE THERAPEUTICS & Design is Accepted & Advertised.
MBRACE THERAPEUTICS & Design is registered under trademark class 99.
The proprietor of MBRACE THERAPEUTICS & Design is MBrace Therapeutics, Inc..
Trademark application 6352148 for MBRACE THERAPEUTICS & Design was filed on 2024-03-18.